BlackRock’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$99.6M Sell
1,550,708
-9,386
-0.6% -$856K ﹤0.01% 2111
2025
Q4
$203M Buy
1,560,094
+31,019
+2% +$4.26M ﹤0.01% 1680
2025
Q3
$165M Buy
1,529,075
+94,441
+7% +$10.3M ﹤0.01% 1783
2025
Q2
$132M Buy
1,434,634
+287,279
+25% +$22.6M ﹤0.01% 1866
2025
Q1
$102M Sell
1,147,355
-32,457
-3% -$2.82M ﹤0.01% 1981
2024
Q4
$90.7M Buy
1,179,812
+113,610
+11% +$7.94M ﹤0.01% 2135
2024
Q3
$45.2M Buy
1,066,202
+141,633
+15% +$4.78M ﹤0.01% 2528
2024
Q2
$24.2M Buy
924,569
+677,644
+274% +$12.8M ﹤0.01% 2857
2024
Q1
$2.25M Buy
246,925
+12,953
+6% +$77.8K ﹤0.01% 3968
2023
Q4
$643K Hold
233,972
﹤0.01% 4365
2023
Q3
$852K Sell
233,972
-29,329
-11% -$161K ﹤0.01% 4285
2023
Q2
$1.57M Sell
263,301
-419,116
-61% -$3.32M ﹤0.01% 4152
2023
Q1
$8.22M Buy
682,417
+294,841
+76% +$3.93M ﹤0.01% 3420
2022
Q4
$3.37M Sell
387,576
-19,472
-5% -$429K ﹤0.01% 3902
2022
Q3
$11.8M Buy
407,048
+21,304
+6% +$975K ﹤0.01% 3339
2022
Q2
$16M Buy
385,744
+311,302
+418% +$21.1M ﹤0.01% 3208
2022
Q1
$7.54M Buy
74,442
+4,054
+6% +$451K ﹤0.01% 3730
2021
Q4
$10.4M Buy
70,388
+19,789
+39% +$4.42M ﹤0.01% 3651
2021
Q3
$12.7M Buy
50,599
+50,513
+58,736% +$17.3M ﹤0.01% 3571
2021
Q2
$40K Buy
+86
New +$36.9K ﹤0.01% 5216

Other funds holding WGS

BlackRock's WGS Position: Q1 2026 in Review

BlackRock reduced its GeneDx Holdings (WGS) stake by 0.6% in Q1 2026, selling an estimated $856K and leaving 1,550,708 shares worth $99.6M. The position accounts for ﹤0.01% of the portfolio, ranked #2111.

BlackRock first reported a position in WGS in Q2 2021 and has held it in 20 quarters since. The position peaked at $203M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • BlackRock held 1,550,708 shares of GeneDx Holdings worth $99.6M as of Q1 2026.
  • BlackRock sold 9,386 GeneDx Holdings shares in Q1 2026, an estimated $856K.
  • GeneDx Holdings made up ﹤0.01% of BlackRock's portfolio in Q1 2026, its #2111 holding.
  • BlackRock first reported a position in GeneDx Holdings in Q2 2021 and has held it in 20 quarters since.
  • BlackRock's GeneDx Holdings position peaked at $203M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on BlackRock's 13F filing for Q1 2026, filed 13 May 2026.